Your browser doesn't support javascript.
loading
Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins.
Sakamoto, Kentaro; Kawamura, Mitsunobu; Kohro, Takahide; Omura, Masao; Watanabe, Takayuki; Ashidate, Keiko; Horiuchi, Toshiyuki; Hara, Hidehiko; Sekine, Nobuo; Chin, Rina; Tsujino, Motoyoshi; Hiyoshi, Toru; Tagami, Motoki; Tanaka, Akira; Mori, Yasumichi; Inazawa, Takeshi; Hirano, Tsutomu; Yamazaki, Tsutomu; Shiba, Teruo.
Afiliación
  • Sakamoto K; Toho University Ohashi Medical Center, Department of Diabetes and Metabolism, Tokyo, Japan.
  • Kawamura M; Tokyo Teishin Hospital, Division of Endocrinology and Metabolism Department of Internal Medicine, Tokyo, Japan.
  • Kohro T; Jichi Medical University, Department of Medical Informatics / Cardiology, Tochigi, Japan.
  • Omura M; Yokohama Rosai Hospital, Department of Endocrinology and Metabolism, Kanagawa, Japan.
  • Watanabe T; Yokohama City Minato Red Cross Hospital, Department of Internal Medicine, Kanagawa, Japan.
  • Ashidate K; Kudanzaka Hospital, Department of Internal Medicine, Tokyo, Japan.
  • Horiuchi T; Tokyo Metropolitan Health Medical Treatment Corporation Toshima Hospital, Department of Endocrinology and Metabolism, Tokyo, Japan.
  • Hara H; Toho University Ohashi Medical Center, Department of Cardiology, Tokyo, Japan.
  • Sekine N; Tokyo Koseinenkin Hospital, Department of Internal Medicine, Tokyo, Japan.
  • Chin R; Tokyo Kyosai Hospital, Department of Internal Medicine, Tokyo, Japan.
  • Tsujino M; Tokyo Metropolitan Tama Medical Center, Department of Internal Medicine, Tokyo, Japan.
  • Hiyoshi T; Japanese Red Cross Medical Center, Tokyo, Japan.
  • Tagami M; Sanraku Hospital, Life-style related Disease Clinic, Tokyo, Japan.
  • Tanaka A; Kagawa Nutrition University, Nutrition Clinic, Tokyo, Japan.
  • Mori Y; Toranomon Hospital, Department of Endocrinology and Metabolism, Tokyo, Japan.
  • Inazawa T; Kashiwa City Hospital, Internal Medicine, Chiba, Japan.
  • Hirano T; Showa University School of Medicine, Department of Medicine Division of Diabetes Metabolism and Endocrinology, Tokyo, Japan.
  • Yamazaki T; The University of Tokyo Hospital, Clinical Research Support Center, Tokyo, Japan.
  • Shiba T; Toho University Ohashi Medical Center, Department of Diabetes and Metabolism, Tokyo, Japan; Mitsui Memorial Hospital, Division of Diabetes and Metabolism, Tokyo Japan.
PLoS One ; 10(9): e0138332, 2015.
Article en En | MEDLINE | ID: mdl-26398887
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Diabetes Mellitus Tipo 2 / Ezetimiba / LDL-Colesterol / Anticolesterolemiantes Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Diabetes Mellitus Tipo 2 / Ezetimiba / LDL-Colesterol / Anticolesterolemiantes Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: Japón